Monthly Archives: April 2023

PSNC’s 2023 Pharmacy Pressures Survey has confirmed the worsening situation for community pharmacies as rising costs and significantly increased workload is putting businesses at greater risk of collapse. The survey of over 6,200 pharmacy premises and 2,000 pharmacy team members shows a very worrying picture of the impact of the current pressures on pharmacies and [...]

The post Pressures Survey confirms rising costs, patient demand and medicine supply issues continue to grip community pharmacy appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Alfuzosin 10mg modified release tablets. MSN/2023/045 Tier 2 – medium impact Date of issue 12th April 2023 There is limited supply of alfuzosin 10mg modified release tablets until w/c 15th May 2023. Alternative alpha-adrenoceptor blockers licensed for the symptomatic treatment of [...]

The post Medicine Supply Notification: Alfuzosin 10mg modified release tablets appeared first on PSNC Website.

Community pharmacy contractors (including head office staff) and community pharmacists are invited to participate in an interview to share their views on the Quality Payments Scheme (QPS) (the previous name for the Pharmacy Quality Scheme (PQS)) and the PQS. ICF (an independent research consultancy) and the University of Manchester are carrying out the evaluation. The [...]

The post Share your views on the Pharmacy Quality Scheme appeared first on PSNC Website.

PSNC, working with Kingston University and the Community Pharmacy IT Group (CP ITG), has launched a short survey to gather feedback about EPS Paperless, Outcomes and Trackability. Please complete the short EPS survey here We would appreciate views from community pharmacy teams,  including those working within multiple group head offices, who are requested to complete [...]

The post Chance to share your views – EPS outcomes and trackability survey appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml (SSP053). SSP053 was due to expire on 15 December 2023 but the end date has been further extended to Friday 12 January 2024. The Department of Health and Social Care (DHSC) has provided an [...]

The post SSP053 for Clarithromycin 125mg/5ml oral suspension further extended appeared first on Community Pharmacy England.